XML 28 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statement of Changes in Equity
$ in Millions
CAD ($)
Attributable to equity holders of the Company
CAD ($)
Common shares
CAD ($)
shares
Contributed surplus
CAD ($)
Accumulated other comprehensive income
CAD ($)
Retained earnings
CAD ($)
Non-controlling interests
CAD ($)
Number of shares (in shares) at Mar. 31, 2022 | shares     317,024,123        
Balances, beginning of year at Mar. 31, 2022 $ 4,086.6 $ 4,009.7 $ 2,224.7 $ 38.6 $ (31.2) $ 1,777.6 $ 76.9
Net income 231.9 222.7       222.7 9.2
Other comprehensive income 257.0 252.9     198.4 54.5 4.1
Total comprehensive (loss) income 488.9 475.6     198.4 277.2 13.3
Exercise of stock options (in shares) | shares     882,167        
Exercise of stock options 16.3 16.3 $ 18.9 (2.6)      
Equity-settled share-based payments expense 6.1 6.1   6.1      
Transactions with non-controlling interests (9.0)           (9.0)
Number of shares (in shares) at Mar. 31, 2023 | shares     317,906,290        
Balances, end of year at Mar. 31, 2023 4,588.9 4,507.7 $ 2,243.6 42.1 167.2 2,054.8 81.2
Net income (296.3) (304.0)       (304.0) 7.7
Other comprehensive income (1.4) (1.4)     (13.2) 11.8  
Total comprehensive (loss) income (297.7) (305.4)     (13.2) (292.2) 7.7
Exercise of stock options (in shares) | shares     405,943        
Exercise of stock options 7.8 7.8 $ 9.3 (1.5)      
Equity-settled share-based payments expense 14.8 14.8   14.8      
Transactions with non-controlling interests (11.2)           (11.2)
Number of shares (in shares) at Mar. 31, 2024 | shares     318,312,233        
Balances, end of year at Mar. 31, 2024 $ 4,302.6 $ 4,224.9 $ 2,252.9 $ 55.4 $ 154.0 $ 1,762.6 $ 77.7